Acorda Therapeutics, Inc.

• 3 Small Biotechs Top Hedge Funds Are Investing In

  By Shas Dey - April 23, 2013 | Tickers: ACOR, ALNY, IDIX

  Small biotech companies have great investment potential if you can identify them properly. A small biotech with a differentiated treatment approach and strong commercialization plans can become a rainmaker. However, given the level of cutting edge technology they use, a layperson without an MD or an advanced degree in statistics can hardly get a grip on these companies and what they are all about. Unless you know just how good more »

• Four Important Biotech Stocks Targeting Unmet Needs

  By Streetwise Reports - September 1, 2012 | Tickers: ACOR, AMRN, NKTR, NBIX

  By George S. Mack, The Life Sciences Report

   

  Biotech rallies need catalysts to be sustained. Market moving events include drug approvals, such as a couple of obesity products from VIVUS Inc. and Arena Pharmaceuticals Inc., as well as a product to help control serum lipids from Amarin Corp. Plc (NASDAQ: AMRN). But the major diagnostic feature of a market that might be putting it all together is merger and acquisition more »

• Former Drug Developer Discovers Next-Generation Biotech Stocks

  By Streetwise Reports - June 22, 2012 | Tickers: ACHN, ACOR, AMRN, IDIX, MDVN

  Former Drug Developer Discovers Next-Generation Biotech Stocks

  By George S. Mack, The Life Sciences Report

  Management is the key ingredient

  Raghuram "Ram" Selvaraju, an analyst I recently interviewed for The Life Sciences Report, began his initial career in translational drug discovery at Serono in 2000 with early and remarkable success. As a young researcher he demonstrated real insight and ability when he discovered the first novel protein candidate ever developed more »

• J.P. Morgan Healthcare Conference Schedule: Day One

  By Brandy Betz - January 8, 2012 | Tickers: ARAY, ACOR, A, ALGN, AMRN, AMGN, AMLN, ARTC, BIIB, BMRN, BRKR, CFN, CTRX, CELG, CNC, COV, DNDN, XRAY, EW, ENDP, EPOC, ESRX, GHDX, GILD, HLS, HTWR, HMSY, HGSI, IDXX, IPXL, INCY, IRWD, MCK, MRX, MDT, MR, MOH, MYL, NVS, ONXX, PRX, PRGO, QSII, REGN, RMD, RIGL, SGEN, ST, SIAL, THC, MDCO, THOR, VRTX, VVUS, WAT, WMGI, ZLTQ

  The 30th Annual J.P. Morgan Healthcare Conference kicks off with a full day of presentations from companies that range from global pharmaceutical leaders to small cap novel pharmaceutical developers and health technology manufacturers. The majority of the presentations will be available through live webcasts with archived replay offered later in the day.

  I will be following (and covering) the novel therapeutic companies that have caught my eye. VIVUS (NASDAQ: VVUSmore »)